- Home
- NVNI vs FGEN Comparison
NVNI vs FGEN Comparison
Compare NVNI & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNI
- FGEN
- Stock Information
- Founded
- NVNI 2019
- FGEN 1993
- Country
- NVNI Brazil
- FGEN United States
- Employees
- NVNI N/A
- FGEN N/A
- Industry
- NVNI
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- NVNI
- FGEN Health Care
- Exchange
- NVNI Nasdaq
- FGEN Nasdaq
- Market Cap
- NVNI 31.5M
- FGEN 33.5M
- IPO Year
- NVNI N/A
- FGEN 2014
- Fundamental
- Price
- NVNI $0.35
- FGEN $7.69
- Analyst Decision
- NVNI
- FGEN Strong Buy
- Analyst Count
- NVNI 0
- FGEN 1
- Target Price
- NVNI N/A
- FGEN $250.00
- AVG Volume (30 Days)
- NVNI 1.2M
- FGEN 74.7K
- Earning Date
- NVNI 08-07-2025
- FGEN 08-05-2025
- Dividend Yield
- NVNI N/A
- FGEN N/A
- EPS Growth
- NVNI N/A
- FGEN N/A
- EPS
- NVNI N/A
- FGEN N/A
- Revenue
- NVNI $31,250,627.00
- FGEN $6,996,000.00
- Revenue This Year
- NVNI $12.05
- FGEN N/A
- Revenue Next Year
- NVNI $15.02
- FGEN N/A
- P/E Ratio
- NVNI N/A
- FGEN N/A
- Revenue Growth
- NVNI 1491.58
- FGEN N/A
- 52 Week Low
- NVNI $0.14
- FGEN $4.50
- 52 Week High
- NVNI $12.19
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- NVNI 50.94
- FGEN 63.73
- Support Level
- NVNI $0.31
- FGEN $5.37
- Resistance Level
- NVNI $0.38
- FGEN $5.73
- Average True Range (ATR)
- NVNI 0.03
- FGEN 0.51
- MACD
- NVNI 0.01
- FGEN 0.32
- Stochastic Oscillator
- NVNI 63.05
- FGEN 97.26
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.